Strategy’s STRC stabilizes near $85, SATA trades at $97.9 amid Bitcoin pressure
Strategy Inc. and Strive Inc. are both running perpetual preferred equity instruments backed, at least philosophically, by their Bitcoin treasury positions. One trades at a discount to par. The other is nearly flat.
Strategy’s STRC is currently stabilizing around $85, against a target par value of $100. Strive’s SATA is trading closer to par, somewhere in the $97 to $98 range.
What these instruments actually are
Both are Nasdaq-listed perpetual preferred stocks, meaning they have no maturity date and sit ahead of common shareholders when it comes to residual asset claims. Neither is directly collateralized by Bitcoin holdings.
STRC currently carries a variable dividend yield in the 11.5% to 12% range. SATA offers a slightly higher annualized rate of 13%. Both emerged in 2025 as part of a broader wave of Bitcoin treasury companies trying to raise capital without diluting their common equity or taking on conventional debt.
STRC has more than $10 billion in notional outstanding. SATA sits at roughly $500 million.
What happened in June and why it matters
June 2026 was not kind to either security. Leverage unwinds and declining Bitcoin prices pushed both STRC and SATA lower during the month.
SATA made a structural move in mid-June that has become a talking point among investors following these securities. Strive shifted SATA to daily dividend payments, contrasting with STRC’s bi-monthly schedule.
Strategy holds a substantially larger Bitcoin reserve than Strive. The company has accumulated hundreds of thousands of Bitcoin over several years. Strive’s position is estimated at somewhere between 13,000 and 20,000 BTC.
What investors should think about before stepping in
STRC trading at $85 against a $100 par target means buyers today are getting the dividend yield plus a potential 17% upside if the instrument ever trades back to par.
SATA trading near par at a 13% annualized rate on a near-par instrument is a cleaner yield calculation than STRC’s discounted setup, which has a return profile that depends heavily on where you think the price goes from here.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The "Outlier" Investment Art in the New Era of Berky

Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India
Chevron is focusing on Argentina and the Mediterranean region, seeking global growth in liquefied natural gas, and plans to reach an agreement with India.

Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge
The upward pressure on energy prices caused by the unresolved Middle East war is mounting. New risks are also approaching, which may keep inflation above the Bank of England’s 2% target for most of next year.

AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales
Bloomberg Intelligence analyst John Murphy stated that the setback in AstraZeneca's breast cancer drug trial could reduce sales in 2035 by $2.6 billion to $3.8 billion.

